Final results: A phase I study of sorafenib and palliative radiation in patients with malignancy in the thorax, abdomen, or pelvis.
A. M. Brade
Research Funding - Bayer
S. W. Kim
No relevant relationships to disclose
C. Chung
No relevant relationships to disclose
J. F. Wan
No relevant relationships to disclose
B. Southwood
No relevant relationships to disclose
N. Chaudary
No relevant relationships to disclose
L. Wang
No relevant relationships to disclose
M. Milosevic
Research Funding - Bayer
A. M. Oza
Research Funding - Bayer